Infectious Canine Hepatitis (ICH) is a highly contagious viral disease primarily impacting dogs. It is caused by Canine Adenovirus type 1 (CAV-1), which affects the liver, kidneys, and endothelial cells. The virus is primarily spread through respiratory secretions and body fluids from infected dogs, as well as through contact with contaminated objects.
Symptoms of ICH usually begin to surface within 4-9 days after exposure. Initial signs may include fever, loss of appetite, nasal discharge, and increased thirst. As the disease progresses, dogs may experience vomiting, diarrhea, abdominal pain, and lethargy. In severe cases, ICH can lead to hemorrhaging, liver failure, and death.
Prevention of ICH primarily involves vaccination, as there is no known cure for the disease. Vaccination can provide immunity against CAV-1 and significantly reduce the risk of infection. It is recommended to follow the vaccination schedule provided by veterinarians to ensure adequate protection.
Treatment for ICH involves supportive care to manage the symptoms and prevent complications. This includes fluid therapy to maintain hydration, medication to control fever and nausea, and monitoring to detect any potential complications. Dogs with severe cases may require hospitalization and close monitoring.
In conclusion, Infectious Canine Hepatitis is a highly contagious viral disease in dogs caused by Canine Adenovirus type 1. It primarily affects the liver, kidneys, and endothelial cells. Prevention through vaccination and early detection are crucial to minimizing the impact of ICH on dogs' health. Veterinary care is essential for the management and treatment of this potentially life-threatening disease.
